| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $7.4M | +64.5% |
| SG&A Expense | $9.2M | +0.1% |
| Operating Income | -$16.6M | -21.2% |
| Interest Expense | $200K | +900.0% |
| Income Tax | $0 | — |
| Net Income | -$18.6M | -67.1% |
| EPS (Basic) | -$0.42 | -23.5% |
| EPS (Diluted) | -$0.42 | -23.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.9M | -65.0% |
| Current Assets | $6.3M | -55.4% |
| Total Assets | $9.6M | -41.5% |
| Current Liabilities | $1.8M | -86.2% |
| Total Liabilities | $3.5M | -74.7% |
| Stockholders' Equity | $6.2M | +125.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.4M | -37.8% |
| Capital Expenditures | $262K | +42.4% |
| Investing Cash Flow | -$262K | -42.4% |
| Financing Cash Flow | $7.6M | -55.3% |
| Free Cash Flow | -$16.7M | -37.8% |